Karim SMM. Once-a-month vaginal administration of prostaglandins E2 and F2α for fertility control. Contraception. 1971;3(3):173–83.
Article
CAS
Google Scholar
Karim SMM. Use of prostaglandin E2 in the management of missed abortion, missed labour, and hydatidiform mole. Br Med J. 1970;3(716):196–7.
Article
CAS
PubMed
PubMed Central
Google Scholar
Karim S, Rao B, Ratnam S, Prasad R, Wong Y, Ilancheran A. Termination of early pregnancy (menstrual induction) with 16-phenoxy-ω-tetranor PGE2 methylsulfonylamide. Contraception 1977;16(4):377–81.
Kahn JG, Becker BJ, Maclsaa L, Amory JK, Neuhaus J, Olkin I, Creinin MD. The efficacy of medical abortion: a meta-analysis. Contraception. 2000;61(1):29–40.
Article
CAS
PubMed
Google Scholar
Kulier R, Kapp N, Gülmezoglu AM, Hofmeyr GJ, Cheng L, Campana A. Medical methods for first trimester abortion. Cochrane Database of Systematic Reviews 2011, Issue 11. Art. No.: CD002855. DOI: https://doi.org/10.1002/14651858.CD002855.pub4.
Blum J, Raghavan S, Dabash R, Ngoc N, Chelli H, Hajri S, Conkling K, Winikoff B. Comparison of misoprostol-only and combined mifepristone-misoprostol regimens for home-based early medical abortion in Tunisia and Vietnam. Int J Gynaecol Obstet. 2012;118(2):166–71.
Article
CAS
PubMed
Google Scholar
Dahiya K, Ahuja K, Dhingra A, Duhan N, Nanda S. Efficacy and safety of mifepristone and buccal misoprostol versus buccal misoprostol alone for medical abortion. Arch Gynecol Obstet. 2012;285(4):1055–8.
Article
PubMed
Google Scholar
Ngoc NT, Blum J, Raghavan S, Nga NT, Dabash R, Diop A, Winikoff B. Comparing two early medical abortion regimens: mifepristone+misoprostol vs. misoprostol alone. Contraception. 2011;83(5):410–7.
Article
PubMed
Google Scholar
Chong E, Tsereteli T, Nguyen NN, Winikoff B. A randomized controlled trial of different buccal misoprostol doses in mifepristone medical abortion. Contraception. 2012;86(3):251–6.
Article
CAS
PubMed
Google Scholar
von Hertzen H, Huong NT, Piaggio G, Bayalag M, Cabezas E, Fang AH, Gemzell-Danielsson K, Hinh ND, Mittal S, Ng EH, Chaturachinda K, Pinter B, Puscasiu L, Savardekar L, Shenoy S, Khomassuridge A, Tuyet HT, Velasco A, Peregoudov A. Misoprostol dose and route after mifepristone for early medical abortion: a randomised controlled noninferiority trial. BJOG. 2010;117(10):1186–96.
Article
Google Scholar
Guest J, Dog PFW, Thomson MAR, Kosseim ML. Randomized controlled trial of the efficacy of same-day administration of mifepristone and misoprostol for termination of pregnancy with the standard 36 to 48 hour protocol. BJOG Int J Obstet Gynecol. 2007;114:207–15.
Article
CAS
Google Scholar
Creinin MD, Schreiber CA, Bednarek P, Lintu H, Wagner MS, Meyn LA. Mifepristone and misoprostol administered simultaneously versus 24 hours apart for abortion: a randomized controlled trial. Obstet Gynecol. 2007;109(4):885–94.
Article
CAS
PubMed
Google Scholar
Verma ML, Singh U, Singh N, Shankhwar P, Srivastava D. Efficacy of misoprostol administration 24 hours after mifepristone for termination of early pregnancy. Indian J Med Sci. 2011;65(12):511–7.
Article
PubMed
Google Scholar
Blanchard K, Shochet T, Coyaji K, Thi Nhu Ngoc N, Winikoff B. Misoprostol alone for early abortion: an evaluation of seven potential regimens. Contraception. 2005;72(2):91–7.
Article
CAS
PubMed
Google Scholar
Covidence systematic review software, Veritas Health Innovation, Melbourne, Australia. Available at www.covidence.org.
Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.handbook.cochrane.org.
World Bank Data Team. New country classifications by income level: 2018-2019. 2018. Available from: https://blogs.worldbank.org/opendata/newcountry-classifications-income-level-2018-2019. Accessed 28 Oct 2018.
Chai J, Wong CY, Ho PC. A randomized clinical trial comparing the short-term side effects of sublingual and buccal routes of misoprostol administration for medical abortions up to 63 days' gestation. Contraception. 2013;87(4):480–5.
Article
CAS
PubMed
Google Scholar
Chawdhary R, Rana A, Pradhan N. Mifepristone plus vaginal misoprostol vs vaginal misoprostol alone for medical abortion in gestation 63 days or less in Nepalese women: a quasi-randomized controlled trial. J Obstet Gynaecol Res. 2009;35(1):78–85.
Article
CAS
PubMed
Google Scholar
Coyaji K, Krishna U, Ambardekar S, Bracken H, Raote V, Mandlekar A, Winikoff B. Are two doses of misoprostol after mifepristone for early abortion better than one? BJOG. 2007;114(3):271–8.
Article
CAS
PubMed
Google Scholar
Dahiya K, Mann S, Nanda S. Randomized trial of oral versus sublingual misoprostol 24 h after mifepristone for medical abortion. Arch Gynecol Obstet. 2011;284(1):59–63.
Article
PubMed
Google Scholar
El-Refaey H, Templeton A. Early abortion induction by a combination of mifepristone and oral misoprostol: a comparison between two dose regimens of misoprostol and their effect on blood pressure. Br J Obstet Gynaecol. 1994;101(9):792–6.
Article
CAS
PubMed
Google Scholar
El-Refaey H, Rajasekar D, Abdalla M, Calder L, Templeton A. Induction of abortion with mifepristone (RU 486) and oral or vaginal misoprostol. N Engl J Med. 1995;332(15):983–7.
Article
CAS
PubMed
Google Scholar
Fekih M, Fathallah K, Ben Regaya L, Bouguizane S, Chaieb A, Bibi M, Khairi H. Sublingual misoprostol for first trimester termination of pregnancy. Int J Gynaecol Obstet. 2010;109(1):67–70.
Article
CAS
PubMed
Google Scholar
Goel A, Mittal S, Taneja BK, Singal N, Attri S. Simultaneous administration of mifepristone and misoprostol for early termination of pregnancy: a randomized controlled trial. Arch Gynecol Obstet. 2011;283(6):1409–13.
Article
CAS
PubMed
Google Scholar
Hamoda H, Ashok PW, Flett GM, Templeton A. A randomised controlled trial of mifepristone in combination with misoprostol administered sublingually or vaginally for medical abortion up to 13 weeks of gestation. BJOG. 2005;112(8):1102–8.
Article
CAS
PubMed
Google Scholar
Jain JK, Dutton C, Harwood B, Meckstroth KR, Mishell DR Jr. A prospective randomized, double-blinded, placebo-controlled trial comparing mifepristone and vaginal misoprostol to vaginal misoprostol alone for elective termination of early pregnancy. Hum Reprod (Oxford, Engl). 2002;17(6):1477–82.
Article
CAS
Google Scholar
Middleton T, Schaff E, Fielding SL, Scahill M, Shannon C, Westheimer E, Wilkinson T, Winikoff B. Randomized trial of mifepristone and buccal or vaginal misoprostol for abortion through 56 days of last menstrual period. Contraception. 2005;72(5):328–32.
Article
CAS
PubMed
Google Scholar
Prasad S, Kumar A, Divya A. Early termination of pregnancy by single-dose 800 μg misoprostol compared with surgical evacuation. Fertil Steril. 2009;91(1):28–31.
Article
CAS
PubMed
Google Scholar
Raghavana S, Comendant R, Digol I, Ungureanu S, Friptu V, Bracken H, Winikoff B. Two-pill regimens of misoprostol after mifepristone medical abortion through 63 days' gestational age: a randomized controlled trial of sublingual and oral misoprostol. Contraception. 2009;79:84–90.
Article
Google Scholar
Raghavan S, Comendant R, Digol I, Ungureanu S, Dondiuc I, Turcanu S, Winikoff B. Comparison of 400 mcg buccal and 400 mcg sublingual misoprostol after mifepristone medical abortion through 63 days’ LMP: a randomized controlled trial. Contraception. 2010;82(6):513–9.
Article
CAS
PubMed
Google Scholar
Schaff EA, Fielding SL, Westhoff C, Ellertson C, Eisinger SH, Stadalius LS, Fuller L. Vaginal misoprostol administered 1, 2, or 3 days after mifepristone for early medical abortion: a randomized trial. JAMA. 2000;284(15):1948–53.
Article
CAS
PubMed
Google Scholar
Schaff EA, Fielding SL, Westhoff C. Randomized trial of oral versus vaginal misoprostol at one day after mifepristone for early medical abortion. Contraception. 2001;64(2):81–5.
Article
CAS
PubMed
Google Scholar
Schaff EA, Fielding SL, Westhoff C. Randomized trial of oral versus vaginal misoprostol 2 days after mifepristone 200 mg for abortion up to 63 days of pregnancy. Contraception. 2002;66(4):247–50.
Article
CAS
PubMed
Google Scholar
Shannon C, Wiebe E, Jacot F, Guilbert E, Dunn S, Sheldon WR, Winikoff B. Regimens of misoprostol with mifepristone for early medical abortion: a randomised trial. BJOG. 2006;113(6):621–8.
Article
CAS
PubMed
Google Scholar
Tang OS, Chan CC, Ng EH, Lee SW, Ho PC. A prospective, randomized, placebo-controlled trial on the use of mifepristone with sublingual or vaginal misoprostol for medical abortions of less than 9 weeks gestation. Hum Reprod (Oxford, Engl). 2003;18(11):2315–8.
Article
CAS
Google Scholar
Tendler R, Bornstein J, Kais M, Masri I, Odeh M. Early versus late misoprostol administration after mifepristone for medical abortion. Arch Gynecol Obstet. 2015;292(5):1051–4.
Article
CAS
PubMed
Google Scholar
Verma ML, Singh U, Singh N, Sankhwar PL, Qureshi S. Efficacy of concurrent administration of mifepristone and misoprostol for termination of pregnancy. Human fertility (Cambridge, Engl). 2017;20(1):43–7.
von Hertzen H, Piaggio G, Huong NT, Arustamyan K, Cabezas E, Gomez M, Khomassuridze A, Shah R, Mittal S, Nair R, Erdenetungalag R, Huong TM, Vy ND, Phuong NT, Tuyet HT, Peregoudov A. Efficacy of two intervals and two routes of administration of misoprostol for termination of early pregnancy: a randomised controlled equivalence trial. Lancet (London, Engl). 2007;369(9577):1938–46.
Article
Google Scholar
Von Hertzen H, Piaggio G, Wojdyla D, Marions L, My Huong NT, Tang OS, Fang AH, Wu SC, Kalmar L, Mittal S, Erdenetungalag R, Horga M, Pretnar-Darovec A, Kapamadzija A, Dickson K, Anh ND, Tai NV, Tuyet HT, Peregoudov A. Two mifepristone doses and two intervals of misoprostol administration for termination of early pregnancy: a randomised factorial controlled equivalence trial. BJOG. 2009;116(3):381–9.
Article
Google Scholar
Winikoff B, Dzuba IG, Creinin MD, Crowden WA, Goldberg AB, Gonzales J, Howe M, Moskowitz J, Prine L, Shannon CS. Two distinct oral routes of misoprostol in mifepristone medical abortion: a randomized controlled trial. Obstet Gynecol. 2008;112(6):1303–10.
Article
CAS
PubMed
Google Scholar